Learn More About VersaVIT 2.0 »

Valeant Pharmaceuticals International, Inc. (NYSE: VRX/TSX: VRX) completed its acquisition of Synergetics USA, Inc. (“Synergetics”) on October 15, 2015. For Investor Relations information on Valeant, click here.

Events

Synergetics® Presents Sterimedix®

Manufacturer of Industry Leading, Single Use Ophthalmic Products

Read More »